Ruth Halaban

1.1k total citations · 1 hit paper
17 papers, 795 citations indexed

About

Ruth Halaban is a scholar working on Molecular Biology, Cell Biology and Immunology. According to data from OpenAlex, Ruth Halaban has authored 17 papers receiving a total of 795 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 6 papers in Cell Biology and 6 papers in Immunology. Recurrent topics in Ruth Halaban's work include Melanoma and MAPK Pathways (6 papers), RNA regulation and disease (4 papers) and melanin and skin pigmentation (4 papers). Ruth Halaban is often cited by papers focused on Melanoma and MAPK Pathways (6 papers), RNA regulation and disease (4 papers) and melanin and skin pigmentation (4 papers). Ruth Halaban collaborates with scholars based in United States, China and Spain. Ruth Halaban's co-authors include Janet M. Cowan, Gisela Moellmann, Mark H. Stoler, Glynis Scott, Jeannette Bennicelli, Dorothee Herlyn, Z Steplewski, Meenhard Herlyn, Gloria Balaban and Aaron M. Newman and has published in prestigious journals such as Nature Medicine, JNCI Journal of the National Cancer Institute and Biochemistry.

In The Last Decade

Ruth Halaban

15 papers receiving 769 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma

2022 180 citations Alexander X. Lozano, Aadel A. Chaudhuri et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruth Halaban United States	10	389	381	230	205	117	17	795
Elizabeth K. Duperret United States	18	435 1.1×	474 1.2×	129 0.6×	476 2.3×	143 1.2×	25	1.1k
Chi‐Ping Day United States	16	400 1.0×	479 1.3×	134 0.6×	251 1.2×	133 1.1×	37	943
Melissa C Adriance United States	7	380 1.0×	472 1.2×	91 0.4×	150 0.7×	154 1.3×	7	805
Esben Pedersen Denmark	12	177 0.5×	528 1.4×	245 1.1×	145 0.7×	117 1.0×	15	838
Maria‐Laura Mancianti United States	12	297 0.8×	548 1.4×	324 1.4×	138 0.7×	78 0.7×	14	1.0k
Victoria Küttner Germany	10	259 0.7×	554 1.5×	183 0.8×	585 2.9×	144 1.2×	12	1.3k
Anissa Chikh United Kingdom	13	215 0.6×	490 1.3×	117 0.5×	100 0.5×	133 1.1×	19	747
Shauna Hegarty Ireland	11	171 0.4×	324 0.9×	75 0.3×	65 0.3×	238 2.0×	12	656
Daniel E. Bassi United States	14	235 0.6×	441 1.2×	233 1.0×	63 0.3×	234 2.0×	19	804
Nicole L. Collins United States	6	355 0.9×	498 1.3×	230 1.0×	85 0.4×	116 1.0×	11	844

Countries citing papers authored by Ruth Halaban

Since Specialization

Citations

This map shows the geographic impact of Ruth Halaban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruth Halaban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruth Halaban more than expected).

Fields of papers citing papers by Ruth Halaban

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruth Halaban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruth Halaban. The network helps show where Ruth Halaban may publish in the future.

Co-authorship network of co-authors of Ruth Halaban

This figure shows the co-authorship network connecting the top 25 collaborators of Ruth Halaban. A scholar is included among the top collaborators of Ruth Halaban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruth Halaban. Ruth Halaban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Yadav, Vipin, Antonella Bacchiocchi, Ruth Halaban, et al.. (2025). Blocking Nitrosylation Induces Immunogenic Cell Death by Sensitizing NRAS -Mutant Melanoma to MEK Inhibitors. Cancer Research. 85(12). 2268–2287. 2 indexed citations

Zheng, Shu-Jian, Haomiao Su, Lichong Yan, et al.. (2025). The ERVK3-1 Microprotein Interacts with the HUSH Complex. Biochemistry. 64(15). 3372–3381.

Bacchiocchi, Antonella, Michael Mak, Xiangyu Gong, et al.. (2025). LZTR1 is a melanoma oncogene that promotes invasion and suppresses apoptosis. Oncogene. 44(41). 3974–3984.

Liu, Tao, Antonella Bacchiocchi, Mengxing Li, et al.. (2024). Ultra-sensitive molecular residual disease detection through whole genome sequencing with single-read error correction. EMBO Molecular Medicine. 16(9). 2188–2209. 4 indexed citations

Osmani, Lais, Wael Ibrahim, Anjela Galan, et al.. (2024). Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma. Oncotarget. 15(1). 507–520. 4 indexed citations

Earland, Noah, Wubing Zhang, Abul Usmani, et al.. (2023). CD4 T cells and toxicity from immune checkpoint blockade. Immunological Reviews. 318(1). 96–109. 9 indexed citations

Lozano, Alexander X., Aadel A. Chaudhuri, Aishwarya Nene, et al.. (2022). T cell characteristics associated with toxicity to immune checkpoint blockade in patients with melanoma. Nature Medicine. 28(2). 353–362. 180 indexed citations breakdown →

Sanmamed, Miguel F., José Luis Perez‐Gracia, Juan P. Fusco, et al.. (2016). Changes in serum IL8 levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small cell lung cancer patients. Annals of Oncology. 27. vi359–vi359. 1 indexed citations

Halaban, Ruth. (2002). COMMENTARY Pigmentation in Melanomas: Changes Manifesting Underlying Oncogenic and Metabolic Activities. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 13(1). 3–8. 26 indexed citations

10.

Halaban, Ruth, et al.. (1997). Molecular cytogenetic analysis of early primary melanoma. Cancer Genetics and Cytogenetics. 98(2). 158–158. 1 indexed citations

11.

Hou, Ling, Gisela Moellmann, Elizabeth Kuklinska, et al.. (1996). Characterization and Subcellular Localization of Human Pmel 17/silver, a 100-kDa (Pre)Melanosomal Membrane Protein Associated With 5,6,-Dihydroxyindole-2-Carboxylic Acid (DHICA) Converting Activity. Journal of Investigative Dermatology. 106(4). 605–610. 69 indexed citations

12.

Halaban, Ruth & Gisela Moellmann. (1993). White Mutants in Mice Shedding Light on Humans. Journal of Investigative Dermatology. 100(2). S176–S185. 47 indexed citations

13.

Halaban, Ruth, et al.. (1992). Growth Factors, Receptor Kinases, and Protein Tyro sine Phosphatases in Normal and Malignant Melanocytes. Journal of Immunotherapy. 12(3). 154–161. 37 indexed citations

14.

Scott, Glynis, et al.. (1991). Localization of Basic Fibroblast Growth Factor mRNA in Melanocytic Lesions by In Situ Hybridization. Journal of Investigative Dermatology. 96(3). 318–322. 80 indexed citations

15.

Halaban, Ruth. (1991). Growth factors and tyrosine protein kinases in normal and malignant melanocytes. Cancer and Metastasis Reviews. 10(2). 129–140. 49 indexed citations

16.

Cowan, Janet M., et al.. (1988). Cytogenetic Analysis of Melanocytes From Premalignant Nevi and Melanomas. JNCI Journal of the National Cancer Institute. 80(14). 1159–1164. 163 indexed citations

17.

Herlyn, Meenhard, Gloria Balaban, Jeannette Bennicelli, et al.. (1985). Primary melanoma cells of the vertical growth phase: similarities to metastatic cells.. PubMed. 74(2). 283–9. 123 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact